Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biological drug use




Abstract


Relapsing polychondritis (RP) is a very rare autoimmune disease characterised by a relapsing inflammation of the cartilaginous tissues (joints, ears, nose, intervertebral discs, larynx, trachea and cartilaginous bronchi), which may progress to long-lasting atrophy and/or deformity of the cartilages. Non-cartilaginous tissues may also be affected, such as the eyes, heart, aorta, inner ear and skin. RP has a long and unpredictable course. Because no randomised therapeutic trials are available, the treatment of RP remains mainly empirical. Minor forms of the disease can be treated with non-steroidal anti-inflammatory drugs, whereas more severe forms are treated with systemic corticosteroids. Life-threatening diseases and corticosteroid-dependent or resistant diseases are an indication for immunosuppressant therapy such as methotrexate, azathioprine, mycophenolate mofetil and cyclophosphamide. Biologics could be given as second-line treatment in patients with an active disease despite the use of steroids and immunosuppressive drugs. Although the biologics represent new potential treatment for RP, very scarce information is available to draw any firm conclusion on their use in RP.


Introduction


Relapsing polychondritis (RP) is a rare autoimmune disease mostly, but not exclusively, affecting the hyaline, elastic and fibrous cartilaginous tissues .




Pathogenesis


The pathophysiology of RP remains largely unknown. Several features, however, suggest that RP is an autoimmune disorder. The inflammatory infiltrate in the affected tissue is polymorph and consists of lymphocytes (mainly CD4+ T cells), macrophages, neutrophils and plasma cells. Infiltration of tissues by different cellular and molecular inflammatory mediators leads to the release of degradative enzymes such as matrix metalloproteinase and reactive oxygen metabolites by inflammatory cells and chondrocytes, and ultimately to the destruction of cartilage and other proteoglycan-rich tissues .


The main hypothesis of the pathophysiology of RP is an autoimmune reaction initially directed against the cartilage, further spreading to non-cartilaginous tissues . The initiating mechanism could be damage to the cartilage, exposing immunogenic epitopes of the chondrocytes or extracellular cartilage matrix . Development of RP following piercing of the cartilage portion of the pinna of the ear and ingestion of glucosamine chondroitin supplement supported this hypothesis. The initial auto-antigens seem indeed to be components of the cartilage. For example, injection of type-II collagen into rats can induce auricular chondritis ; immunisation of mice with certain HLA-DQ molecules along with type-II collagen can also cause auricular chondritis and polyarthritis ; and injection of matrilin-1, a specific tracheal cartilage protein, into rats reproduces the respiratory lesions of RP . As in some other autoimmune disorders, susceptibility to RP has been reported to be significantly associated with the presence of HLA-DR4 . The extent of organ involvement in RP appears to be negatively associated with HLA-DR6 .


Autoantibodies against cartilage, collagen (mostly type II, including other types – IX, X, and XI), matrilin-1 and cartilage oligomeric matrix proteins (COMPs) have been found in patients with RP . The diagnostic value of these autoantibodies is extremely poor as they are found in a limited number of patients and they are not specific to RP. For example, serum type-II collagen antibodies, which are found in approximately 30% of patients with RP, can also be detected in rheumatoid arthritis . Autoreactive T lymphocytes specific to collagen have also been found in RP . T lymphocytes in RP have a Th1 profile, i.e. the majority of them produce interferon-gamma .


The levels of serum monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1-beta (MIP-1beta) and interleukin-8 (IL-8) are increased during flares of the disease, highlighting the role of monocytes and macrophages, and their recruitment into injured tissues .




Pathogenesis


The pathophysiology of RP remains largely unknown. Several features, however, suggest that RP is an autoimmune disorder. The inflammatory infiltrate in the affected tissue is polymorph and consists of lymphocytes (mainly CD4+ T cells), macrophages, neutrophils and plasma cells. Infiltration of tissues by different cellular and molecular inflammatory mediators leads to the release of degradative enzymes such as matrix metalloproteinase and reactive oxygen metabolites by inflammatory cells and chondrocytes, and ultimately to the destruction of cartilage and other proteoglycan-rich tissues .


The main hypothesis of the pathophysiology of RP is an autoimmune reaction initially directed against the cartilage, further spreading to non-cartilaginous tissues . The initiating mechanism could be damage to the cartilage, exposing immunogenic epitopes of the chondrocytes or extracellular cartilage matrix . Development of RP following piercing of the cartilage portion of the pinna of the ear and ingestion of glucosamine chondroitin supplement supported this hypothesis. The initial auto-antigens seem indeed to be components of the cartilage. For example, injection of type-II collagen into rats can induce auricular chondritis ; immunisation of mice with certain HLA-DQ molecules along with type-II collagen can also cause auricular chondritis and polyarthritis ; and injection of matrilin-1, a specific tracheal cartilage protein, into rats reproduces the respiratory lesions of RP . As in some other autoimmune disorders, susceptibility to RP has been reported to be significantly associated with the presence of HLA-DR4 . The extent of organ involvement in RP appears to be negatively associated with HLA-DR6 .


Autoantibodies against cartilage, collagen (mostly type II, including other types – IX, X, and XI), matrilin-1 and cartilage oligomeric matrix proteins (COMPs) have been found in patients with RP . The diagnostic value of these autoantibodies is extremely poor as they are found in a limited number of patients and they are not specific to RP. For example, serum type-II collagen antibodies, which are found in approximately 30% of patients with RP, can also be detected in rheumatoid arthritis . Autoreactive T lymphocytes specific to collagen have also been found in RP . T lymphocytes in RP have a Th1 profile, i.e. the majority of them produce interferon-gamma .


The levels of serum monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1-beta (MIP-1beta) and interleukin-8 (IL-8) are increased during flares of the disease, highlighting the role of monocytes and macrophages, and their recruitment into injured tissues .




Epidemiology


The rarity of RP makes epidemiological data very scarce. Its incidence is poorly documented and probably underestimated. An estimated incidence of 3.5 cases per million people has been reported in a study in Rochester (Minnesota, USA) . A prevalence study by the Department of Defense beneficiary population leads to an evaluation of 4.5 cases per million . In a recent UK study, the prevalence of RP was 9.0 (95% confidence interval (CI) 7.6–10.5) per million and its incidence was 0.71 (95% CI 0.55–0.91) per million per year .


The disease usually begins between the age of 30 and 60 years, on average at approximately 50 years , although paediatric or geriatric onset forms have been described. Paediatric cases do not have specific features except a high prevalence of a personal or family history of other autoimmune diseases. The cartilaginous involvement does not delay growth . The disease affects men and women equally , although some series show a slight female predominance . Forms of the disease associated with myelodysplastic syndromes are mostly seen in men >60 years .




Clinical features


The typical clinical representation is a combination of chondritis – which is necessary for the diagnosis – with inflammation of other proteoglycan-rich tissues such as the eyes, heart, blood vessel or inner ears. Chondritis is the presenting feature in only one-third of cases. A recent Japanese multi-institutional study of 239 RP cases – globally representative of several series published previously – gave the following prevalence of organ involvement: auricular chondritis, 78.2%; nasal chondritis, 39.3%; airway, 50.0% (and upper airway collapse, 20.5%); eye, 46.0%; joint, 38.9%; inner ear, 27.2%; and cardiac involvement, 7.1% . Patients often experience significant delay before the diagnosis.


Systemic features


Fatigue is present during and between flares. Fever could be observed occasionally in severe flares and unexplained prolonged fever may be the presenting symptom of RP.


Ear involvement


The most common and suggestive feature of the disease is chondritis of the pinna of the ear, which is present in up to 90% of patients during the course of the disease . Chondritis can be acute, subacute or chronic and unilateral or bilateral. In the acute presentation, the pinna of the ear (helix, antihelix, tragus, antitragus and external auditory canal) is inflamed, swollen, painful and red. Typically, the inflammation spares the ear lobe, which does not contain cartilage ( Fig. 1 ). The external auditory canal may be obstructed by the inflammatory infiltrate or collapsed, particularly at its opening, leading to conductive hearing loss and/or infectious otitis externa. The inflammation may include surrounding retroauricular soft tissues and could be sometimes associated with lymphadenopathy. Patients cannot press their ear on the telephone handset or the pillow. The inflammation lasts for a couple of days to a few weeks and often spontaneously resolves. Complications include disappearance of the auricular cartilage resulting in drooping of the pinna, which becomes floppy and contorted, namely ‘cauliflower ear’ ( Fig. 2 ). Conversely, the pinna can be thickened and/or rigidified with calcification and deformity of the cartilaginous structure.




Fig. 1


Outer ear chondritis . The pinna of the ear is red, hot, and swollen. Inflammation spares the ear lobe, which is not cartilaginous.



Fig. 2


‘Cauliflower ear’ . Repeated episodes of chondritis cause a deformity: the normal relief outlines have disappeared and the ear appears thickened. The external auditory canal has collapsed, and its opening can no longer be seen.


The cochlea and/or vestibule may be affected by vasculitis or autoantibodies . This feature is characterised by sudden or less often progressive sensorineural hearing loss and/or vestibular dysfunction (vertigo or dizziness), which may be unilateral or bilateral. Acute hearing losses can reverse with corticosteroids . Serous otitis media and Eustachian tube obstruction are less common . In Michet et al.’s series, hearing loss and vertigo affected 26% and 13% of patients, respectively .


Nose involvement


Nasal chondritis is less symptomatic than auricular chondritis . In the acute form, patients experience pain at the base of the nose, occasionally with a swelling, a sensation of fullness of the nasal bridge and occasionally with local inflammatory signs due to the swelling and tenderness of the distal part of the nasal septum. Patients can have nasal crusting, obstruction, rhinorrhoea or epistaxis . Of note, epistaxis, crusting, ulceration of the nasal mucosa and perforation of the nasal septum are more suggestive of granulomatosis with polyangiitis (Wegener’s disease) than RP.


Nasal chondritis is often combined with ophthalmological or auricular inflammation and may progress rapidly to permanent destruction of the septal cartilage with a characteristic saddle-nose deformity ( Fig. 3 ). This deformity may also occur painlessly and progressively without any acute flares. In Michet et al.’s series, saddle nose affected 29% of patients .




Fig. 3


‘Saddle-nose’ deformity . Repeated episodes of chondritis in the nose cause the nasal septum to collapse. This deformity may occasionally develop as a low-grade painless process.


Involvement of the larynx, trachea and major airways


Airway involvement usually involves both the trachea and main bronchi. It may extent to the larynx and intermediary bronchi. Isolated chondritis of the trachea or the larynx can be seen . It is an important cause of mortality, particularly because of the inspiratory collapse of the tracheobronchial tree . Early search for laryngotracheal involvement is therefore mandatory and acute inflammatory episodes must be treated early and intensively. A higher female prevalence of respiratory tract involvement has been reported but is still controversial .


Involvement of the larynx is characterised by dry cough, hoarseness, dysphonia, aphonia, stridor, choking and tenderness over the tracheal or anterior thyroid cartilage responsible for anterior neck pain worsened by palpation of the cartilaginous structures . Inflammation of the mucosa and infiltration of the cartilage structures are sometimes visible on endoscopy above the thyroid and next to the first tracheal rings. The laryngeal involvement can, although rarely, progress to stenosis with respiratory failure and laryngeal dyspnoea. Tracheobronchial disease is more serious and is often difficult to diagnose early as it may be the only chondritis and its symptoms may be late and misleading. These include dry cough, dyspnoea and occasionally wheezing. This feature of the disease may mimic atypical asthma . Respiratory distress and/or sudden tracheal collapse can occur in acute forms .


The lesions consist of cartilaginous and peri-cartilaginous inflammation with a thickening of the tracheobronchial wall leading to the stenosis of the lumen. This inflammation may progress to fibrosis with fixed stenosis for which anti-inflammatory treatment is ineffective. Tracheobronchomalacia may also occur due to progressive destruction of the cartilage with inspiratory collapse of the lumen . Involvement of the large airways is a concern when it is fixed as it is difficult to access for endoscopic or surgical procedures and is also frequently complicated by atelectasis and/or bacterial infection.


Respiratory function test (RFT) is the most sensitive test to determine airway involvement in RP . RFTs should include spirometry, peak expiratory and inspiratory flow-volume loop and airway resistance to assess the obstructive consequences of the disease .


Respiratory involvement should also be investigated by a chest radiograph and specifically by computed tomography (CT) of the respiratory tract and chest ( Fig. 4 ) . The larynx and trachea are most commonly affected. The disease may also involve the airways more distally to the level of subsegmental bronchi. At the early stage of the disease, CT shows smooth anterior and lateral airway wall thickening with sparing of the posterior membranous wall. There is often an increased attenuation of the cartilages (ranging from subtle to frankly calcified). In more advanced disease, thickening of airway walls become circumferential because the posterior (non-cartilaginous) wall of the trachea and main bronchi is thickened. At this stage, focal or diffuse luminal narrowing of the trachea and bronchi may occur resulting from fibrosis following cartilaginous destruction. Loss of cartilaginous support due to cartilaginous inflammation and destruction also results in excessive dynamic expiratory collapsibility (tracheobronchomalacia). Expiratory air trapping is frequently observed involving one lung, lobes, segments or lobules. Laryngotracheal reconstructions in different three-dimensional planes using virtual endoscopy (3D CT) can be used to analyse the patency of the respiratory tract. End of inspiration images are used to assess fixed airway narrowing and those during forced exhalation assess tracheobronchomalacia and air trapping .




Fig. 4


Severe tracheal and bronchial involvement in RP . CT scan of the chest in a 34-year-old male patient suffering from RP. Axial (A) and coronal oblique reformatted (B) CT images show thickening and hyperattenuation (calcified) of the anterior and lateral walls of the trachea, main bronchi, right intermediate bronchus and left upper lobar bronchus. Note the sparing of the posterior wall of the airways. On axial images with lung window settings (C), luminal narrowing is visible on the right intermediate bronchus (red arrow) and the lingular bronchus (yellow arrow). On expiratory CT scan (bottom right), gas trapping is present in the left upper lobe (yellow star).


Because of the increased risk of perforation and exacerbation of the inflammation and the small amount of information it provides, bronchoscopy should be carefully considered although it may nevertheless be performed . It can show airway-wall oedema, stenosis and tracheobronchomalacia . An acceptable correlation appears between 3D CT and bronchoscopy findings, except for the diagnosis of tracheobronchomalacia . Cartilage biopsies have been obtained from the trachea or main bronchus . In our experience, this procedure is never essential and we do not recommend it.


Costal chondritis


This is characterised by parasternal pain (costochondral cartilage) and/or pain in the floating ribs, which can be reproduced on pressure. Costochondral chondritis is sometimes accompanied by local swelling. It is highly suggestive of the disease. In severe cases, this chondritis can result in dislocation of the ribs and in pectus deformity .


Musculoskeletal involvement


This is the second most common feature of RP. The involvement may be either oligoarthritis or polyarthritis affecting the small and large joints. It is usually asymmetrical and intermittent. It affects both large and small joints and the parasternal joints (sternomanubrial junction and sternoclavicular joints) . Inflammatory flares may resolve without treatment. The disease is neither erosive nor deforming apart from cases in which the RP is associated with rheumatoid arthritis. RP may present as an axial rheumatic disease although the combination with spondyloarthritis should be considered if spinal radiological changes are present. Arthralgia without true clinical arthritis is very common and other rheumatological features may exist including tendinitis, tenosynovitis, enthesopathy and myalgia.


Ophthalmological involvement


Ophthalmological involvement is reported in 20–60% of patients . It is often contemporaneous with other features of RP although it could precede the development of chondritis by several years. Various types of involvement may occur. The most common are episcleritis, scleritis and conjunctivitis . Published biopsies report polymorph inflammatory infiltrates and vasculitis . Episcleritis is often satellite to visceral involvement and carries a good prognosis. This is generally responsive to simple local anti-inflammatory treatment. Scleritis is the most common ocular manifestation and often progresses in combination with extra-ophthalmological disease particularly auricular or nasal chondritis and audiovestibular damage . All forms of scleritis may occur, ranging from diffuse anterior ( Fig. 5 ) to nodular or necrotising that can, although rarely, progresses to perforation of the eye globe. Severe scleritis leaves the complication of scleromalacia, suggesting the diagnosis retrospectively ( Fig. 6 ). A recent study reported that RP-associated scleritis was often bilateral (92.3%), diffuse (76.9%), recurrent (84.6%), sometimes with decreased vision (46.2%), anterior uveitis (38.5%), necrosis (23.1%), peripheral keratitis (15.4%), optic neuritis (15.4%) and ocular hypertension (30.8%) .




Fig. 5


Diffuse scleritis.



Fig. 6


Scleromalacia . Scleromalacia is a complication of episodes of severe anterior scleritis.


Other involvements of the eye may be encountered : simple conjunctivitis, conjunctival ‘salmon-patch’ mass, chemosis, eyelid and periorbital oedema, simple keratitis, peripheral ulcerative keratitis, thinning of the cornea, corneal melting, anterior uveitis, retinal vasculitis, chorioretinitis, ischaemic optic neuropathy and orbital inflammatory pseudotumour.


Cardiovascular involvement


Cardiac complications are more prevalent in older and male patients and are the second cause of death in RP . The most common lesion is aortic valve disease due to progressive dilatation of the aortic ring often associated with an ascending thoracic aortic aneurysm . This lesion occurs insidiously in the course of the disease and requires repeated monitoring with echocardiography. Direct inflammatory valve destruction may occur but is rare. Mitral disease is rarely reported. In Michet et al.’s series aortic regurgitation and mitral regurgitation affected 4% and 2% of patients, respectively .


The second most common cardiovascular feature is acquired thoracic aortic aneurysm, which is located and usually limited to the aortic root and the ascending thoracic aorta. This develops in 5–7% of patients . The main mechanism is generally slowly progressive aortitis with inflammation and gradual destruction of the medial layers . This lesion is generally progressive and carries a risk of ruptured aorta. Extension to the major arterial vessels and abdominal aorta is rare.


Other cardiovascular involvements have been described, including pericarditis, atrioventricular conduction block (which can resolve on corticosteroid therapy), arrhythmias, vasculitis of the great vessels with stenotic and thrombotic lesions similar to Takayasu arteritis and aneurysms in vessels other than the aorta .


Skin features


These are more frequent with concomitant myelodysplastic syndrome . Skin lesions affect one-third of the patients : buccal aphthous ulcers, erythema nodosum-like nodules, purpura, papules, sterile pustules, superficial phlebitis, livedo reticularis, skin ulcerations, distal necrosis and neutrophilic dermatoses including erythema elevatum diutinum, Sweet’s syndrome, urticaria and angio-oedema. A biopsy may show leukocytoclastic vasculitis (occasionally necrotic and rarely lymphocytic), small-vessel thromboses, neutrophilic infiltrates or panniculitis.


Nervous system involvement


Involvement of the peripheral or central nervous system (CNS) is uncommon, occurring in approximately 3% of the cases of RP . A recent literature review reported approximately 20 cases of encephalitis or meningoencephalitis in RP . In this review, the male-to-female ratio was 16:3. The neurological symptoms are not different from encephalitis or meningoencephalitis of other causes: headache, confusion, disorientation, memory disturbances, visual disturbances, speech disturbances, cognitive impairment, seizures and wandering. Several cases presented as limbic encephalitis and/or dementia. Cerebrospinal fluid analysis showed a predominantly mononuclear pleocytosis and brain MRI showed bilateral high-signal-intensity lesions on FLAIR (fluid-attenuated inversion recovery) and T2-weighted images of the medial temporal lobe or subcortical and periventricular deep white matter . Histopathological examination shows neurological loss and gliosis with non-specific inflammation of the meninges and both white and grey matters spreading cortically without evidence of vasculitis . The CNS involvement usually improves on high-dose corticosteroid therapy . The peripheral neurological involvement is similar to that observed in the vasculitis: paralysis of the cranial nerve (second, sixth, seventh and eighth cranial nerves being the most frequently affected) and polyneuritis .


Renal involvement


The predominant lesions are mild mesangial expansion and cell proliferation as well as segmental necrotising glomerulonephritis with crescents without or with small deposits of immune complexes . In the series reported by Chang-Miller et al., renal involvement was observed in 22.5% of patients . This is far rarer in our practice. The differential diagnosis of granulomatosis with polyangiitis should be considered. Cases of IgA nephropathy and tubulointerstitial nephritis have been reported .




Laboratory findings


The most common laboratory findings are non-specific changes in the levels of acute-phase reactants, particularly with higher levels of serum C-reactive protein (CRP). Of note, >10% of patients have a normal CRP level even during flares of the disease . Active phases of the disease may be associated with an increase in leukocytes, neutrophils, eosinophils, monocytes and platelets. Anti-cartilage and anti-collagen (type II) antibodies are only of limited clinical use because of their poor sensitivity and specificity. These antibodies are tested only by a few laboratories and are not requested in routine practice. Homogeneous or speckled antinuclear antibodies are found after excluding cases associated with lupus or mixed connective tissue disorder in approximately 10% of patients by conventional immunofluorescence . Anti-neutrophil cytoplasmic antibodies (ANCAs) may be found in RP . However, the differential diagnosis with granulomatosis with polyangiitis should be considered, particularly, if the ANCAs are cytoplasmic and associated with anti-PR3 antibodies.




Clinical forms





  • RP is associated with other autoimmune diseases in one-third of cases . The list of these diseases is long including thyroiditis; vasculitis of the large, small and medium vessels; Behçet’s disease; rheumatoid arthritis; ankylosing spondylitis; systemic lupus erythematosus; antiphospholipid syndrome; and chronic inflammatory bowel diseases. According to Michet et al., 5–14% of patients have cutaneous leukocytoclastic angiitis and 10% have multi-system microvascular disease responsible for peripheral and central neurological complications and mesangial glomerulonephritis .



  • RP is occasionally satellite to myelodysplastic syndrome particularly in male patients >60 years . Overall prognosis depends generally on the haematological disease and not on RP.





Diagnosis and diagnostic criteria for RP


There are no specific laboratory tests for the diagnosis of RP. The diagnosis is based on a set of clinical evidence and imaging studies, occasionally assisted by a biopsy of the injured cartilage. Biopsy is not essential and, in practice, is rarely performed. When it is performed, the easiest site to access is the outer ear. The biopsy should be performed during acute chondritis. This shows loss of basophilic staining of the cartilage matrix secondary to proteoglycan rarefaction and infiltration of lymphocytes, macrophages, neutrophils and plasmocytes into the perichondrium and/or cartilage. This infiltrate destroys the cartilage to different degrees. The cartilage is then replaced by scarring fibrosis with degeneration and rarefaction of chondrocyte (which become vacuolated and pyknotic) and matrix with areas of granulation and fibrosis . The perichondrial outline is replaced by a cellular and vascular inflammatory infiltrate . Areas of calcification and bone formation may be observed within the granulation tissue . Immunofluorescence studies may show immunoglobulin and complement deposition along the chondrofibrous junction and in the perichondral vessel walls . 18 F-fluorodeoxyglucose positron emission tomography–CT (FDG PET–CT) scanning may help to diagnose occult trachea–bronchial or aortic involvement and/or atypical clinical features of RP, such as fever of unknown origin without clinical signs of chondritis .


The first diagnostic criteria to be used are those published by McAdam . They include recurrent chondritis of both auricles ; non-erosive inflammatory polyarthritis ; chondritis of nasal cartilages ; inflammation of ocular structures including conjunctivitis, keratitis, scleritis/episcleritis and/or uveitis; chondritis of the respiratory tract involving laryngeal and/or tracheal cartilages and cochlear or vestibular damage manifested by neurosensory hearing loss; tinnitus; and/or vertigo. Three to six clinical features should be essential for diagnosis. A cartilage biopsy according to these criteria is not mandatory. Nevertheless, in unclear cases, it is important to obtain a biopsy from the affected cartilage. Damiani and Levine proposed that the diagnosis of RP could be made in patients meeting three of the McAdam’s criteria even without biopsy confirmation or with a single McAdam criterion if histological evidence of chondritis was present or when chondritis was found in two or more separate anatomic locations with response to steroids and/or dapsone . Michet’s criteria avoid the need for a biopsy and are often used at present ( Table 1 ) . As many patients do not meet the current diagnostic criteria, Mathew et al. classify patients as having partial RP if they have recurrent chondritis with deformity plus vestibular dysfunction, ocular inflammation or inflammatory arthritis .


Nov 10, 2017 | Posted by in RHEUMATOLOGY | Comments Off on Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biological drug use

Full access? Get Clinical Tree

Get Clinical Tree app for offline access